Acute Migraine

Males and Females 18 years and older

The trial is being conducted to see how effective the medication zavegepant is in the possible treatment of migraines.

Eligibility

• Medical Diagnosis of migraines for at least 1 year.
• Migraine attacks, on average, lasting about 4 – 72 hours if untreated
• Must be able to distinguish migraine attacks from tension/cluster headaches.
• Must use 2 acceptable methods of contraception to avoid pregnancy throughout the study

Trial Duration

The trial will last up to 11 weeks involving 3 visits to our office

Compensation

You will be paid via check at the completion of the trial.